1
|
Liu YE, Mabene Y, Camelo S, Rueda ZV, Pelissari DM, Johansen FDC, Huaman MA, Avalos-Cruz T, Alarcón VA, Ladutke LM, Bergman M, Cohen T, Goldhaber-Fiebert JD, Croda J, Andrews JR. Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected impacts of policy alternatives: A mathematical modeling study. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2024:2024.04.23.24306238. [PMID: 39108530 PMCID: PMC11302613 DOI: 10.1101/2024.04.23.24306238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 08/10/2024]
Abstract
Background Tuberculosis incidence is increasing in Latin America, where the incarcerated population has nearly quadrupled since 1990. The full impact of incarceration on the tuberculosis epidemic, accounting for effects beyond prisons, has never been quantified. Methods We calibrated dynamic compartmental transmission models to historical and contemporary data from Argentina, Brazil, Colombia, El Salvador, Mexico, and Peru, which comprise approximately 80% of the region's incarcerated population and tuberculosis burden. Using historical counterfactual scenarios, we estimated the transmission population attributable fraction (tPAF) for incarceration and the excess population-level burden attributable to increasing incarceration prevalence since 1990. We additionally projected the impact of alternative incarceration policies on future population tuberculosis incidence. Findings Population tuberculosis incidence in 2019 was 29.4% (95% UI, 23.9-36.8) higher than expected without the rise in incarceration since 1990, corresponding to 34,393 (95% UI, 28,295-42,579) excess incident cases across countries. The incarceration tPAF in 2019 was 27.2% (95% UI, 20.9-35.8), exceeding estimates for other risk factors like HIV, alcohol use disorder, and undernutrition. Compared to a scenario where incarceration rates remain stable at current levels, a gradual 50% reduction in prison admissions and duration of incarceration by 2034 would reduce population tuberculosis incidence by over 10% in all countries except Mexico. Interpretation The historical rise in incarceration in Latin America has resulted in a large excess tuberculosis burden that has been under-recognized to-date. International health agencies, ministries of justice, and national tuberculosis programs should collaborate to address this health crisis with comprehensive strategies, including decarceration. Funding National Institutes of Health.
Collapse
Affiliation(s)
- Yiran E Liu
- Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA
| | - Yasmine Mabene
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA
| | - Sergio Camelo
- Institute for Computational and Mathematical Engineering, Stanford University, Stanford, California, USA
| | - Zulma Vanessa Rueda
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada
- School of Medicine, Universidad Pontificia Bolivariana, Medellin, Colombia
| | | | | | - Moises A Huaman
- Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| | - Tatiana Avalos-Cruz
- Dirección de Prevención y Control de la Tuberculosis, Ministerio de Salud, Lima, Perú
| | - Valentina A Alarcón
- Dirección de Prevención y Control de la Tuberculosis, Ministerio de Salud, Lima, Perú
| | | | - Marcelo Bergman
- Center for Latin American Studies on Insecurity and Violence, National University of Tres de Febrero, Argentina
| | - Ted Cohen
- Department of Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, Connecticut, USA
| | - Jeremy D Goldhaber-Fiebert
- Department of Health Policy, Stanford University, Stanford, California, USA
- Center for Health Policy, Freeman Spogli Institute, Stanford University, Stanford, California, USA
| | - Julio Croda
- Department of Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, Connecticut, USA
- Departamento de Clínica Médica, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil
- Fiocruz Mato Grosso do Sul, Campo Grande, Brazil
| | - Jason R Andrews
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA
| |
Collapse
|
2
|
Silva Júnior JNDB, Couto RDM, Alves LC, da Silva DA, Heráclio IDL, Pelissari DM, Andrade KB, Oliveira PB. Trends in tuberculosis incidence and mortality coefficients in Brazil, 2011-2019: analysis by inflection points. Rev Panam Salud Publica 2023; 47:e152. [PMID: 37937313 PMCID: PMC10627430 DOI: 10.26633/rpsp.2023.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Accepted: 07/17/2023] [Indexed: 11/09/2023] Open
Abstract
Objective To analyze the temporal trend of tuberculosis incidence and mortality rates in Brazil between 2011 and 2019. Methods This was an ecological time series study of tuberculosis incidence and mortality rates in Brazil between 2011 and 2019. Data were extracted from the Notifiable Disease Information System and the Mortality Information System, and population estimates were from the Brazilian Institute of Geography and Statistics. Trends were analyzed by Joinpoint regression, which recognizes inflection points for temporal analysis. Results The average incidence rate of tuberculosis in Brazil in the period was 35.8 cases per 100 000 population. From 2011 to 2015, this coefficient had an annual percentage change of -1.9% (95% CI [-3.4, -0.5]) followed by an increase of 2.4% (95% CI [0.9, 3.9]) until 2019. The average mortality rate between 2011 and 2019 was 2.2 deaths per 100 000 population, with an average annual percentage change of -0.4% (95% CI [-1.0, 0.2]). Amazonas was the only state with an increase in the annual average percentage variation for the incidence rate (3.2%; 95% CI [1.3, 5.1]) and mortality rate (2.7%; 95% CI [1.0, 4.4]) over the years, while Rio de Janeiro state had an increasing inflection for incidence from 2014 to 2019 (2.4%; 95% CI [1.4, 3.5]) and annual average of decreasing percentage variation (-3.5%; 95% CI [-5.0, -1.9]). Conclusions During the period analyzed, a decreasing trend in incidence was observed between 2011 and 2015, and an increasing trend for the period from 2015 to 2019. On the other hand, no change in the trend for mortality was found in Brazil.
Collapse
Affiliation(s)
- José Nildo de Barros Silva Júnior
- Secretaria de Vigilância em SaúdeMinistry of HealthBrasília, DFBrazilSecretaria de Vigilância em Saúde, Ministry of Health, Brasília, DF, Brazil
| | - Rodrigo de Macedo Couto
- Secretaria de Vigilância em SaúdeMinistry of HealthBrasília, DFBrazilSecretaria de Vigilância em Saúde, Ministry of Health, Brasília, DF, Brazil
| | - Layana Costa Alves
- Secretaria de Vigilância em SaúdeMinistry of HealthBrasília, DFBrazilSecretaria de Vigilância em Saúde, Ministry of Health, Brasília, DF, Brazil
| | - Daiane Alves da Silva
- Secretaria de Vigilância em SaúdeMinistry of HealthBrasília, DFBrazilSecretaria de Vigilância em Saúde, Ministry of Health, Brasília, DF, Brazil
| | - Isabela de Lucena Heráclio
- Secretaria de Vigilância em SaúdeMinistry of HealthBrasília, DFBrazilSecretaria de Vigilância em Saúde, Ministry of Health, Brasília, DF, Brazil
| | - Daniele Maria Pelissari
- Secretaria de Vigilância em SaúdeMinistry of HealthBrasília, DFBrazilSecretaria de Vigilância em Saúde, Ministry of Health, Brasília, DF, Brazil
| | - Kleydson Bonfim Andrade
- Pan American Health OrganizationBrasília, DFBrazilPan American Health Organization, Brasília, DF, Brazil
| | - Patrícia Bartholomay Oliveira
- Secretaria de Vigilância em SaúdeMinistry of HealthBrasília, DFBrazilSecretaria de Vigilância em Saúde, Ministry of Health, Brasília, DF, Brazil
| |
Collapse
|